| Style | Citing Format |
|---|---|
| MLA | Hajivalizadeh S, Akhondzadeh S. "Novel Osteoporosis Therapeutic Targets Derived From Medical Biotechnology." Avicenna Journal of Medical Biotechnology, vol. 16, no. 1, 2024, pp. 1-2. |
| APA | Hajivalizadeh S, Akhondzadeh S (2024). Novel Osteoporosis Therapeutic Targets Derived From Medical Biotechnology. Avicenna Journal of Medical Biotechnology, 16(1), 1-2. |
| Chicago | Hajivalizadeh S, Akhondzadeh S. "Novel Osteoporosis Therapeutic Targets Derived From Medical Biotechnology." Avicenna Journal of Medical Biotechnology 16, no. 1 (2024): 1-2. |
| Harvard | Hajivalizadeh S, Akhondzadeh S (2024) 'Novel Osteoporosis Therapeutic Targets Derived From Medical Biotechnology', Avicenna Journal of Medical Biotechnology, 16(1), pp. 1-2. |
| Vancouver | Hajivalizadeh S, Akhondzadeh S. Novel Osteoporosis Therapeutic Targets Derived From Medical Biotechnology. Avicenna Journal of Medical Biotechnology. 2024;16(1):1-2. |
| BibTex | @article{ author = {Hajivalizadeh S and Akhondzadeh S}, title = {Novel Osteoporosis Therapeutic Targets Derived From Medical Biotechnology}, journal = {Avicenna Journal of Medical Biotechnology}, volume = {16}, number = {1}, pages = {1-2}, year = {2024} } |
| RIS | TY - JOUR AU - Hajivalizadeh S AU - Akhondzadeh S TI - Novel Osteoporosis Therapeutic Targets Derived From Medical Biotechnology JO - Avicenna Journal of Medical Biotechnology VL - 16 IS - 1 SP - 1 EP - 2 PY - 2024 ER - |